Aio-studien-ggmbh
Clinical trials sponsored by Aio-studien-ggmbh, explained in plain language.
-
New drug combo shows promise in rare colorectal cancer trial
Disease control CompletedThis study tested a combination of three drugs (encorafenib, binimetinib, and cetuximab) given before surgery to people with a specific type of colorectal cancer that has a BRAF V600E mutation. Only 2 patients took part, and the main goal was to see how much the tumor shrank afte…
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for bile duct cancer: two drug combos tested
Disease control CompletedThis study tested two different chemotherapy combinations in 93 people with advanced bile duct cancer that could not be removed by surgery. One group received a new drug called Nal-IRI along with standard drugs 5-FU and leucovorin, while the other group received gemcitabine plus …
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated May 01, 2026 16:01 UTC